Locations:
Search IconSearch

Neurosciences

19-NEU-258-Woman-MS-Wheelchair-640241694
March 27, 2019/Neurosciences/Research

A Window into Patients’ Perceptions of the Risks of Multiple Sclerosis Therapies

Large survey shows wide variability in risk tolerance, high levels of risk aversion

16-NEU-1793-Outcomes-650×450

Surgery for Epilepsy Control: Time to Overcome Reluctance About a Safe Treatment Option

Patients who fail two or more antiepileptic meds should be referred for evaluation

19-NEU-136-rehab-transfer-650×450

From Hospital to Inpatient Rehabilitation with 6 Clicks

Pilot program expedites patient transfers by removing precertification requirements

19-NEU-230-ghoshEpilepsia-hero-650×450

Insights on Glucocorticoid Receptors’ Role in Drug-Resistant Epilepsy

In vitro model of blood-brain barrier points to potential therapeutic target

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

19-NEU-224-Fox-Sones-Award-650×450

Dr. Robert Fox Receives Innovation Award for Advances in Progressive Multiple Sclerosis (Video)

Honor recognizes imaging and therapeutic insights behind slowing of brain atrophy

19-NEU-220-JimenezCannabis-650×450

Cannabis for Chronic Pain: Not a Simple Solution

Any benefits are inconclusive while harms are well established

19-NEU-122_CQD_650x450_hero
February 19, 2019/Geriatrics

PET Ligand GE-180 Cleared for Testing to Assess Inflammation in Neurodegenerative Disease

Cleveland Clinic IND application is first approved in Parkinson’s and Alzheimer’s

18-NEU-5941-Benzel-650×450
February 14, 2019/Neurosciences/Education

Benzel Symposium Prior to AANS Meeting Will Showcase Superb Spine Caregiving

Course honoring the master neurosurgeon packs a substantive punch

BackPage 67 of 88Next

Advertisement

Ad